Dr Emma Jane Rose

Dr Rose is the Associate Director for the Program for Translational Research on Adversity and Neurodevelopment (P-TRAN) in the Edna Bennett Prevention Research Center at The Pennsylvania State University (Penn State; USA). Her research focuses on delineating trait, state, and situational factors that mediate and/or moderate neurodevelopmental trajectories that predict differential risk and responsivity and which are relevant for substance abuse prevention and treatment.  Dr Rose graduated with a PhD. in Psychiatry from the University of Edinburgh (Edinburgh, UK) in 2004 and subsequently undertook fellowships in addiction neurobiology at the National Institute on Drug Abuse (Baltimore, USA); 2004-2009) and in neuropsychiatric genetics at Trinity College Dublin (Ireland; 2009-2012).  Following this, she returned to the US for a staff scientist position at RTI International (2012-2014) and then moved to the Center for Translational Research on Adversity, Neurodevelopment and Substance Abuse (C-TRANS) at the University of Maryland School of Medicine. Drs. Rose moved with her current research program to Penn State in 2015, where she and Dr. Diana Fishbein (P-TRAN director) have continued to grow and develop their interdisciplinary program of translational neuroscience research, which involves principal investigators and their teams from 15 labs across 6 different departments and three colleges at Penn State and is largely focused on leveraging the understanding of the neurobiological mechanisms by which adversity drives suboptimal outcomes for improved primary and secondary preventive interventions.